Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...

With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up ...

“Our proprietary intranasal platform has the potential to enhance drug delivery bioavailability. We believe that intranasal delivery has the potential to improve patient outcomes by providing a ...

Amgen (AMGN) is a biotech company based in California. It specializes in developing treatments for cardiovascular conditions, oncology, hematology, neurology, bone health, nephrology, and more.

Researchers suggest that many metamorphic proteins have an 'underlying temperature dependence.' If confirmed, this would mean that temperature -- and cold temperature in particular -- plays a ...

With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading biotechnology company with a multi-billion-dollar market capitalization to advance the ...

In the biotechnology and chemical spaces, genus claims are often sought by patent applicants to protect not only a specific product of interest, ...

For Amanda Seyfried, who’s played both a trend-obsessed popular girl in Mean Girls and a biotech fraud in The Dropout, taking ...

Hydrodynamic cavitation mediated phycocyanin extraction from Spirulina paving way for other high value compound extraction coupled with biogas production from post extracted residue to realise a ...

BEIJING - Sinovac Biotech Ltd. (NASDAQ:SVA), a prominent biopharmaceutical company in China with a market capitalization of $45.31 million, has confirmed the implementation of a court order ...

is once again making layoffs. The Cambridge-Montreal biotech announced a restructuring last month that it said would result in headcount reductions. On Tuesday, Repare specified in a securities ...